389 related articles for article (PubMed ID: 18596226)
1. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
[TBL] [Abstract][Full Text] [Related]
3. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
Iclozan C; Yu Y; Liu C; Liang Y; Yi T; Anasetti C; Yu XZ
Biol Blood Marrow Transplant; 2010 Feb; 16(2):170-8. PubMed ID: 19804837
[TBL] [Abstract][Full Text] [Related]
4. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
[TBL] [Abstract][Full Text] [Related]
5. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
[TBL] [Abstract][Full Text] [Related]
7. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
10. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
Carlson MJ; West ML; Coghill JM; Panoskaltsis-Mortari A; Blazar BR; Serody JS
Blood; 2009 Feb; 113(6):1365-74. PubMed ID: 18957685
[TBL] [Abstract][Full Text] [Related]
11. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
[TBL] [Abstract][Full Text] [Related]
12. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
13. Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.
Ma Q; Li D; Nurieva R; Patenia R; Bassett R; Cao W; Alekseev AM; He H; Molldrem JJ; Kroll MH; Champlin RE; Sale GE; Afshar-Kharghan V
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1174-81. PubMed ID: 22664751
[TBL] [Abstract][Full Text] [Related]
14. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
[TBL] [Abstract][Full Text] [Related]
15. Adoptively transferred donor IL-17-producing CD4
Cai Y; Ma S; Liu Y; Gong H; Cheng Q; Hu B; Wu Y; Yu X; Dong C; Sun K; Wu D; Liu H
Cell Mol Immunol; 2018 Mar; 15(3):233-245. PubMed ID: 27748733
[TBL] [Abstract][Full Text] [Related]
16. IL-17 contributes to CD4-mediated graft-versus-host disease.
Kappel LW; Goldberg GL; King CG; Suh DY; Smith OM; Ligh C; Holland AM; Grubin J; Mark NM; Liu C; Iwakura Y; Heller G; van den Brink MR
Blood; 2009 Jan; 113(4):945-52. PubMed ID: 18931341
[TBL] [Abstract][Full Text] [Related]
17. A critical role for donor-derived IL-22 in cutaneous chronic GVHD.
Gartlan KH; Bommiasamy H; Paz K; Wilkinson AN; Owen M; Reichenbach DK; Banovic T; Wehner K; Buchanan F; Varelias A; Kuns RD; Chang K; Fedoriw Y; Shea T; Coghill J; Zaiken M; Plank MW; Foster PS; Clouston AD; Blazar BR; Serody JS; Hill GR
Am J Transplant; 2018 Apr; 18(4):810-820. PubMed ID: 28941323
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.
Shi Y; Liu XF; Zhuang Y; Zhang JY; Liu T; Yin Z; Wu C; Mao XH; Jia KR; Wang FJ; Guo H; Flavell RA; Zhao Z; Liu KY; Xiao B; Guo Y; Zhang WJ; Zhou WY; Guo G; Zou QM
J Immunol; 2010 May; 184(9):5121-9. PubMed ID: 20351183
[TBL] [Abstract][Full Text] [Related]
20. Targeting Inflammatory T Helper Cells
Buchele V; Abendroth B; Büttner-Herold M; Vogler T; Rothamer J; Ghimire S; Ullrich E; Holler E; Neurath MF; Hildner K
Front Immunol; 2018; 9():1138. PubMed ID: 29910804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]